Frontiers Announces New Director of Clinical and Translational Science Unit Fairway

University of Kansas Medical Center

Laura Mussulman, MA, MPH, has been named the Director of Clinical and Translational Science Unit (CTSU) Fairway at the University of Kansas Medical Center, effective Monday, November 8, 2021. Mussulman will direct all CTSU Fairway operations and supervise the CTSU nursing and research staff. She will also partner with the other Frontiers CTSUs at KUMC Rainbow, KU Wichita, and Children's Mercy Kansas City.

"We are thrilled for Laura to join our CTSU Fairway team as the new Director," said Jeffrey Burns, MD, MS, Professor of Neurology at the University of Kansas Medical Center and Scientific Director of CTSU Fairway. "She brings over two decades of experience managing multi-million-dollar NIH clinical trials to this position as well as the skills needed to manage the daily operations of the CTSU."

Mussulman recently served as the Project Director on both the RADx-UP Kansas project - a joint venture funded by the National Center for Advancing Translational Sciences and led by community partners and KUMC that focuses on addressing COVID-19 testing-related inequities for underserved populations - and a newly awarded CDC grant in partnership with the Kansas Department of Health and Environment and Local Health Equity Action Teams addressing COVID-19 health disparities. In addition, she also served as the Operational Director of the University of Kansas Hospital's inpatient tobacco treatment program: UKANQUIT.

"From my first discussions with Drs. Burns and Sosnoff, I saw a natural alignment between the mission of the Clinical and Translational Science Unit and my strong passion for research to improve population health," Mussulman said. "I am truly honored to lead the CTSU Fairway team, and I look forward to collaborating with investigators and key stakeholders to further the institutions commitment to improving the health of the community."

CTSA Program In Action Goals
Goal 2: Engage Patients and Communities in Every Phase of the Translational Process
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan